| SC | 00-26926 | 57-0965380 | ||||||||||||
| (State or other jurisdiction of incorporation) |
(Commission File Number) | (IRS Employer Identification No.) |
||||||||||||
| Title of Each Class | Trading Symbol | Name of Each Exchange on Which Registered | ||||||||||||
| Common Stock, no par value | SCSC | NASDAQ Global Select Market | ||||||||||||
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||||
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||||
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||||
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | ||||
| Emerging growth company | ☐ | ||||
| Exhibit Number |
Description | ||||
| 99.1 | |||||
| 99.2 | |||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | ||||
| ScanSource, Inc. | |||||||||||||||||||||||
| Date: | May 8, 2025 | /s/ STEVE JONES | |||||||||||||||||||||
| Steve Jones | |||||||||||||||||||||||
| Senior Executive Vice President and Chief Financial Officer | |||||||||||||||||||||||
| Contact: | ||||||||
| Steve Jones | Mary M. Gentry | |||||||
| Senior EVP, Chief Financial Officer | SVP, Finance and Treasurer | |||||||
| ScanSource, Inc. | ScanSource, Inc. | |||||||
| (864) 286-4302 | (864) 286-4892 | |||||||
| Third Quarter Summary | ||||||||||||||||||||
| Q3 FY25 | Q3 FY24 | Change | ||||||||||||||||||
| (in thousands, except percentages and per share data) | ||||||||||||||||||||
Select reported measures: |
||||||||||||||||||||
| Net sales | $ | 704,847 | $ | 752,599 | -6.3% | |||||||||||||||
| Gross profit | $ | 100,202 | $ | 94,481 | 6.1% | |||||||||||||||
| Gross profit margin % | 14.2 | % | 12.6 | % | 166bp | |||||||||||||||
| Operating income | $ | 22,339 | $ | 17,542 | 27.3% | |||||||||||||||
| GAAP net income | $ | 17,431 | $ | 12,806 | 36.1% | |||||||||||||||
| GAAP diluted EPS | $ | 0.74 | $ | 0.50 | 48.0% | |||||||||||||||
Select Non-GAAP measures*: |
||||||||||||||||||||
| Adjusted EBITDA | $ | 35,053 | $ | 33,095 | 5.9% | |||||||||||||||
| Adjusted EBITDA margin % | 4.97 | % | 4.40 | % | 57bp | |||||||||||||||
| Non-GAAP net income | $ | 20,298 | $ | 17,461 | 16.2% | |||||||||||||||
| Non-GAAP diluted EPS | $ | 0.86 | $ | 0.69 | 24.6% | |||||||||||||||
| Note: Margin % reflects measure as a percentage of sales. | ||||||||||||||||||||
* Represents non-GAAP financial measures. For more information and a reconciliation to the most directly comparable GAAP financial measure, see "Non-GAAP Financial Information" below as well as the accompanying Supplementary Information. | ||||||||||||||||||||
| FY25 Annual Outlook | Prior FY25 Annual Outlook | |||||||||||||
| Net sales | Approximately $3 billion | $3.1 billion to $3.5 billion | ||||||||||||
| Adjusted EBITDA (non-GAAP) | $140 million to $145 million | $140 million to $160 million | ||||||||||||
| Free cash flow (non-GAAP) | At least $70 million | At least $70 million | ||||||||||||
| ScanSource, Inc. and Subsidiaries | |||||||||||
| Condensed Consolidated Balance Sheets (Unaudited) | |||||||||||
| (in thousands, except share data) | |||||||||||
| March 31, 2025 | June 30, 2024* | ||||||||||
| Assets | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ | 146,287 | $ | 185,460 | |||||||
|
Accounts receivable, less allowance of $27,032 at March 31, 2025
and $20,684 at June 30, 2024
|
562,820 | 581,523 | |||||||||
| Inventories | 476,206 | 512,634 | |||||||||
| Prepaid expenses and other current assets | 124,955 | 125,082 | |||||||||
| Total current assets | 1,310,268 | 1,404,699 | |||||||||
| Property and equipment, net | 29,997 | 33,501 | |||||||||
| Goodwill | 228,835 | 206,301 | |||||||||
| Identifiable intangible assets, net | 67,815 | 37,634 | |||||||||
| Deferred income taxes | 17,947 | 19,902 | |||||||||
| Other non-current assets | 70,346 | 76,995 | |||||||||
| Total assets | $ | 1,725,208 | $ | 1,779,032 | |||||||
| Liabilities and Shareholders’ Equity | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable | $ | 540,765 | $ | 587,984 | |||||||
| Accrued expenses and other current liabilities | 68,263 | 65,616 | |||||||||
| Current portion of contingent consideration | 1,737 | — | |||||||||
| Income taxes payable | 13,224 | 7,895 | |||||||||
| Current portion of long-term debt | 7,861 | 7,857 | |||||||||
| Total current liabilities | 631,850 | 669,352 | |||||||||
| Long-term debt, net of current portion | 130,163 | 136,149 | |||||||||
| Borrowings under revolving credit facility | — | 50 | |||||||||
| Long-term portion of contingent consideration | 17,510 | — | |||||||||
| Other long-term liabilities | 43,939 | 49,226 | |||||||||
| Total liabilities | 823,462 | 854,777 | |||||||||
| Commitments and contingencies | |||||||||||
| Shareholders’ equity: | |||||||||||
Preferred stock, no par value; 3,000,000 shares authorized, none issued |
— | — | |||||||||
Common stock, no par value; 45,000,000 shares authorized, 22,894,413 and 24,243,848 shares issued and outstanding at March 31, 2025 and June 30, 2024, respectively |
— | 26,370 | |||||||||
| Retained earnings | 1,023,399 | 1,013,738 | |||||||||
| Accumulated other comprehensive loss | (121,653) | (115,853) | |||||||||
| Total shareholders’ equity | 901,746 | 924,255 | |||||||||
| Total liabilities and shareholders’ equity | $ | 1,725,208 | $ | 1,779,032 | |||||||
| *Derived from audited financial statements. | |||||||||||
| ScanSource, Inc. and Subsidiaries | |||||||||||||||||||||||
| Condensed Consolidated Income Statements (Unaudited) | |||||||||||||||||||||||
| (in thousands, except per share data) | |||||||||||||||||||||||
| Quarter ended March 31, | Nine months ended March 31, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Net sales | $ | 704,847 | $ | 752,599 | $ | 2,227,924 | $ | 2,513,696 | |||||||||||||||
| Cost of goods sold | 604,645 | 658,118 | 1,924,380 | 2,211,958 | |||||||||||||||||||
| Gross profit | 100,202 | 94,481 | 303,544 | 301,738 | |||||||||||||||||||
| Selling, general and administrative expenses | 69,698 | 66,574 | 215,324 | 208,930 | |||||||||||||||||||
| Depreciation expense | 2,320 | 2,690 | 8,079 | 8,449 | |||||||||||||||||||
| Intangible amortization expense | 4,941 | 3,752 | 14,300 | 11,982 | |||||||||||||||||||
| Restructuring and other charges | — | 3,923 | 5,381 | 3,923 | |||||||||||||||||||
| Change in fair value of contingent consideration | 904 | — | 2,047 | — | |||||||||||||||||||
| Operating income | 22,339 | 17,542 | 58,413 | 68,454 | |||||||||||||||||||
| Interest expense | 1,836 | 2,001 | 5,914 | 10,947 | |||||||||||||||||||
| Interest income | (2,841) | (2,652) | (8,193) | (6,096) | |||||||||||||||||||
| Gain on sale of business | — | — | — | (14,533) | |||||||||||||||||||
| Other (income) expense, net | (882) | 241 | (6,206) | 991 | |||||||||||||||||||
| Income before income taxes | 24,226 | 17,952 | 66,898 | 77,145 | |||||||||||||||||||
| Provision for income taxes | 6,795 | 5,146 | 15,440 | 16,181 | |||||||||||||||||||
| Net income | $ | 17,431 | $ | 12,806 | $ | 51,458 | $ | 60,964 | |||||||||||||||
| Per share data: | |||||||||||||||||||||||
| Net income per common share, basic | $ | 0.75 | $ | 0.51 | $ | 2.17 | $ | 2.44 | |||||||||||||||
| Weighted-average shares outstanding, basic | 23,275 | 25,025 | 23,746 | 24,982 | |||||||||||||||||||
| Net income per common share, diluted | $ | 0.74 | $ | 0.50 | $ | 2.13 | $ | 2.41 | |||||||||||||||
| Weighted-average shares outstanding, diluted | 23,604 | 25,437 | 24,165 | 25,291 | |||||||||||||||||||
| ScanSource, Inc. and Subsidiaries | |||||||||||
| Condensed Consolidated Statements of Cash Flows (Unaudited) | |||||||||||
| (in thousands) | |||||||||||
| Nine months ended March 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| Cash flows from operating activities: | |||||||||||
| Net income | $ | 51,458 | $ | 60,964 | |||||||
| Adjustments to reconcile net income to net cash provided by (used in) operating activities: | |||||||||||
| Gain on sale of business | — | (14,533) | |||||||||
| Depreciation and amortization | 23,095 | 21,217 | |||||||||
| Amortization of debt issue costs | 289 | 289 | |||||||||
| Provision for doubtful accounts | 7,699 | 5,863 | |||||||||
| Share-based compensation | 8,388 | 7,729 | |||||||||
| Deferred income taxes | 1,938 | (1,565) | |||||||||
| Change in fair value of contingent consideration | 2,047 | — | |||||||||
| Finance lease interest | 69 | 70 | |||||||||
| Changes in operating assets and liabilities, net of acquisitions: | |||||||||||
| Accounts receivable | 13,441 | 143,774 | |||||||||
| Inventories | 34,576 | 226,878 | |||||||||
| Prepaid expenses and other assets | 8,013 | (28,163) | |||||||||
| Other non-current assets | 4,344 | 6,022 | |||||||||
| Accounts payable | (50,359) | (117,860) | |||||||||
| Accrued expenses and other liabilities | (5,632) | 11,338 | |||||||||
| Income taxes payable | 5,338 | (5,115) | |||||||||
| Net cash provided by operating activities | 104,704 | 316,908 | |||||||||
| Cash flows from investing activities: | |||||||||||
| Capital expenditures | (5,769) | (7,285) | |||||||||
| Cash paid for business acquisitions, net of cash acquired | (56,673) | — | |||||||||
| Proceeds from sale of business, net of cash transferred | 2,569 | 17,978 | |||||||||
| Net cash (used in) provided by investing activities | (59,873) | 10,693 | |||||||||
| Cash flows from financing activities: | |||||||||||
| Borrowings on revolving credit | 38,336 | 1,242,915 | |||||||||
| Repayments on revolving credit | (38,386) | (1,421,895) | |||||||||
| Repayments on long-term debt, net | (5,982) | (5,040) | |||||||||
| Borrowings (repayments) on finance lease obligation | (818) | (585) | |||||||||
| Exercise of stock options | 9,504 | 4,626 | |||||||||
| Taxes paid on settlement of equity awards | (4,819) | (2,794) | |||||||||
| Common stock repurchased | (81,259) | (21,168) | |||||||||
| Net cash used in financing activities | (83,424) | (203,941) | |||||||||
| Effect of exchange rate changes on cash and cash equivalents | (580) | (788) | |||||||||
| (Decrease) increase in cash and cash equivalents | (39,173) | 122,872 | |||||||||
| Cash and cash equivalents at beginning of period | 185,460 | 36,178 | |||||||||
| Cash and cash equivalents at period end | $ | 146,287 | $ | 159,050 | |||||||
| ScanSource, Inc. and Subsidiaries | |||||||||||
| Supplementary Information (Unaudited) | |||||||||||
| (in thousands, except percentages) | |||||||||||
| Non-GAAP Financial Information: | |||||||||||
| Quarter ended March 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| Reconciliation of Net Income to Adjusted EBITDA: | |||||||||||
| Net income (GAAP) | $ | 17,431 | $ | 12,806 | |||||||
| Plus: Interest expense | 1,836 | 2,001 | |||||||||
| Plus: Income taxes | 6,795 | 5,146 | |||||||||
| Plus: Depreciation and amortization | 7,492 | 6,742 | |||||||||
| EBITDA (non-GAAP) | 33,554 | 26,695 | |||||||||
| Plus: Change in fair value of contingent consideration | 904 | — | |||||||||
| Plus: Share-based compensation | 2,896 | 2,388 | |||||||||
| Plus: Acquisition and divestiture costs | 204 | 511 | |||||||||
| Plus: Cyberattack restoration costs | 71 | 93 | |||||||||
| Plus: Restructuring costs | — | 3,923 | |||||||||
| Plus: Tax recovery | (1,820) | (515) | |||||||||
| Plus: Insurance recovery, net of payments | (756) | — | |||||||||
| Adjusted EBITDA (numerator for Adjusted ROIC) (non-GAAP) | $ | 35,053 | $ | 33,095 | |||||||
| Invested Capital Calculations: | |||||||||||
| Equity – beginning of the period | $ | 900,662 | $ | 953,601 | |||||||
| Equity – end of the period | 901,746 | 944,051 | |||||||||
| Plus: Change in fair value of contingent consideration, net | 681 | — | |||||||||
| Plus: Share-based compensation, net | 2,176 | 1,784 | |||||||||
| Plus: Acquisition and divestiture costs | 204 | 511 | |||||||||
| Plus: Cyberattack restoration costs, net | 54 | 69 | |||||||||
| Plus: Restructuring costs, net | — | 2,935 | |||||||||
| Plus: Insurance recovery, net | (570) | — | |||||||||
| Plus: Tax recovery, net | (1,201) | (1,648) | |||||||||
| Average equity | 901,876 | 950,652 | |||||||||
Average funded debt (a) |
140,207 | 153,131 | |||||||||
| Invested capital (denominator for Adjusted ROIC) (non-GAAP) | $ | 1,042,083 | $ | 1,103,783 | |||||||
Adjusted return on invested capital ratio (Adjusted ROIC), annualized(b) |
13.6% | 12.1% | |||||||||
(a) Average funded debt is calculated as the average daily amounts outstanding on short-term and long-term interest-bearing debt. | |||||||||||
(b) The annualized adjusted EBITDA amount is divided by days in the quarter times 365 days per year, or 366 days for leap year. There were 90 days in the current quarter and 91 days in the prior-year quarter. | |||||||||||
| ScanSource, Inc. and Subsidiaries | |||||||||||||||||
| Supplementary Information (Unaudited) | |||||||||||||||||
| Net Sales by Segment: | |||||||||||||||||
| Quarter ended March 31, | |||||||||||||||||
| 2025 | 2024 | % Change | |||||||||||||||
| Specialty Technology Solutions: | (in thousands) | ||||||||||||||||
| Net sales, reported | $ | 678,433 | $ | 729,834 | (7.0) | % | |||||||||||
Foreign exchange impact (a) |
8,702 | — | |||||||||||||||
| Less: Acquisitions | (6,660) | — | |||||||||||||||
| Non-GAAP net sales | $ | 680,475 | $ | 729,834 | (6.8) | % | |||||||||||
| Intelisys & Advisory: | |||||||||||||||||
| Net sales, reported | $ | 26,414 | $ | 22,765 | 16.0 | % | |||||||||||
Foreign exchange impact (a) |
3 | — | |||||||||||||||
| Less: Acquisitions | (2,662) | — | |||||||||||||||
| Non-GAAP net sales | $ | 23,755 | $ | 22,765 | 4.3 | % | |||||||||||
| Consolidated: | |||||||||||||||||
| Net sales, reported | $ | 704,847 | $ | 752,599 | (6.3) | % | |||||||||||
Foreign exchange impact (a) |
8,705 | — | |||||||||||||||
| Less: Acquisitions | (9,322) | — | |||||||||||||||
| Non-GAAP net sales | $ | 704,230 | $ | 752,599 | (6.4) | % | |||||||||||
(a) Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the quarter ended March 31, 2025 into U.S. dollars using the average foreign exchange rates for the quarter ended March 31, 2024. | |||||||||||||||||
| ScanSource, Inc. and Subsidiaries | ||||||||||||||||||||
| Supplementary Information (Unaudited) | ||||||||||||||||||||
| Net Sales by Revenue Type: | ||||||||||||||||||||
| Quarter ended March 31, | ||||||||||||||||||||
| 2025 | 2024 | % Change | ||||||||||||||||||
| (in thousands) | ||||||||||||||||||||
| Revenue by product/service: | ||||||||||||||||||||
| Products and services | $ | 665,229 | $ | 724,505 | (8.2) | % | ||||||||||||||
Recurring revenue(a) |
39,618 | 28,094 | 41.0 | % | ||||||||||||||||
| $ | 704,847 | $ | 752,599 | (6.3) | % | |||||||||||||||
(a) Recurring revenue represents primarily agency commissions, SaaS, subscriptions, and hardware rentals. | ||||||||||||||||||||
| ScanSource, Inc. and Subsidiaries | |||||||||||||||||
| Supplementary Information (Unaudited) | |||||||||||||||||
| Net Sales by Geography: | |||||||||||||||||
| Quarter ended March 31, | |||||||||||||||||
| 2025 | 2024 | % Change | |||||||||||||||
| United States and Canada: | (in thousands) | ||||||||||||||||
| Net sales, as reported | $ | 656,964 | $ | 671,246 | (2.1) | % | |||||||||||
| Less: Acquisitions | (9,322) | — | |||||||||||||||
| Non-GAAP net sales | $ | 647,642 | $ | 671,246 | (3.5) | % | |||||||||||
| Brazil: | |||||||||||||||||
Net sales, reported(a) |
$ | 47,883 | $ | 81,353 | (41.1) | % | |||||||||||
Foreign exchange impact(b) |
8,705 | — | |||||||||||||||
| Non-GAAP net sales | $ | 56,588 | $ | 81,353 | (30.4) | % | |||||||||||
| Consolidated: | |||||||||||||||||
| Net sales, reported | $ | 704,847 | $ | 752,599 | (6.3) | % | |||||||||||
Foreign exchange impact(b) |
8,705 | — | |||||||||||||||
| Less: Acquisitions | (9,322) | — | |||||||||||||||
| Non-GAAP net sales | $ | 704,230 | $ | 752,599 | (6.4) | % | |||||||||||
(a) Countries outside of the United States, Canada and Brazil represent $0.1 million, or 0.2% of sales, for the quarter ended March 31, 2025 and $0.1 million, or 0.2% of sales, for the quarter ended March 31, 2024. | |||||||||||||||||
(b) Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the quarter ended March 31, 2025 into U.S. dollars using the average foreign exchange rates for the quarter ended March 31, 2024. | |||||||||||||||||
| Free Cash Flow: | |||||||||||||||||||||||
| Quarter ended March 31, | Nine months ended March 31, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| GAAP operating cash flow | $ | 66,058 | $ | 160,152 | $ | 104,704 | $ | 316,908 | |||||||||||||||
| Less: Capital expenditures | (1,420) | (2,420) | (5,769) | (7,285) | |||||||||||||||||||
| Free cash flow (non-GAAP) | $ | 64,638 | $ | 157,732 | $ | 98,935 | $ | 309,623 | |||||||||||||||
| ScanSource, Inc. and Subsidiaries | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Supplementary Information (Unaudited) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| (in thousands, except per share data) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reconciliation of Other Non-GAAP Financial Information: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Quarter ended March 31, 2025 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| GAAP Measure | Intangible amortization expense | Change in fair value of contingent consideration | Acquisition & divestiture costs (a) |
Restructuring costs | Insurance recovery, net | Tax recovery | Cyberattack restoration costs | Non-GAAP measure | ||||||||||||||||||||||||||||||||||||||||||||||||
| (in thousands, except per share data) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SG&A expenses | $69,698 | $— | $— | $(204) | $— | $— | $1,820 | $(71) | $71,243 | |||||||||||||||||||||||||||||||||||||||||||||||
| Operating income | 22,339 | 4,941 | 904 | 204 | — | — | (1,820) | 71 | 26,639 | |||||||||||||||||||||||||||||||||||||||||||||||
| Pre-tax income | 24,226 | 4,941 | 904 | 204 | — | (756) | (1,820) | 71 | 27,770 | |||||||||||||||||||||||||||||||||||||||||||||||
| Net income | 17,431 | 3,699 | 681 | 204 | — | (570) | (1,201) | 54 | 20,298 | |||||||||||||||||||||||||||||||||||||||||||||||
| Diluted EPS | $0.74 | $0.16 | $0.03 | $0.01 | $— | $(0.02) | $(0.05) | $— | $0.86 | |||||||||||||||||||||||||||||||||||||||||||||||
| Quarter ended March 31, 2024 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| GAAP Measure | Intangible amortization expense | Change in fair value of contingent consideration | Acquisition & divestiture costs (a) |
Restructuring costs | Insurance recovery, net | Tax recovery | Cyberattack restoration costs | Non-GAAP measure | ||||||||||||||||||||||||||||||||||||||||||||||||
| (in thousands, except per share data) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SG&A expense | $66,574 | $— | $— | $(511) | $(3,923) | $— | $515 | $(93) | $66,485 | |||||||||||||||||||||||||||||||||||||||||||||||
| Operating income | 17,542 | 3,752 | — | 511 | 3,923 | — | (515) | 93 | 25,306 | |||||||||||||||||||||||||||||||||||||||||||||||
| Pre-tax income | 17,952 | 3,752 | — | 511 | 3,923 | — | (515) | 93 | 25,716 | |||||||||||||||||||||||||||||||||||||||||||||||
| Net income | 12,806 | 2,788 | — | 511 | 2,935 | — | (1,648) | 69 | 17,461 | |||||||||||||||||||||||||||||||||||||||||||||||
| Diluted EPS | $0.50 | $0.11 | $— | $0.02 | $0.12 | $— | $(0.06) | $— | $0.69 | |||||||||||||||||||||||||||||||||||||||||||||||